ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Push to Get Exceptions, Adjustments For Clinical Research In DRG Regulations Gaining Momentum

July 22, 1983

In Brief: ICC Had Only Planning, Not Core Support Grant; Number Of Ro1s In ’79 Understated

June 23, 1978

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

CTEP Publishes Final Version of Plan for Assigning Intellectual Property Rights On Correlative Research

April 8, 2011

Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says

April 27, 1979

Horvitz Wins BMS Award In Neuroscience; Group Room To Discuss Congressional Issues.

February 22, 2002